Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-10-26 Schoenberg Mark Chief Medical Officer Exercise or conversion +208 19,444
2020-10-26 Schoenberg Mark Chief Medical Officer Sale −101 $20.95 $2K 19,343
2020-10-26 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −208 1,042
2020-10-15 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion +4,917 12,805
2020-10-15 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −976 $21.80 $21K 11,829
2020-10-15 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −407 $21.82 $9K 11,422
2020-10-15 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −1,017 $21.72 $22K 10,405
2020-10-15 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −833 1,667
2020-10-15 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −2,084 2,082
2020-10-15 PFREUNDSCHUH PETER P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −2,000 4,000
2020-10-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,808 201,501
2020-10-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,808 132,112
2020-10-01 Henderson Molly Chief Financial Officer Grant or award · Stock Option (Right to Buy) +60,000 60,000
2020-10-01 Henderson Molly Chief Financial Officer Grant or award · Restricted Stock Units +15,000 15,000
2020-10-01 Smith Jason Drew General Counsel Grant or award · Employee Stock Option (right to buy) +60,000 60,000
2020-10-01 Smith Jason Drew General Counsel Grant or award · Restricted Stock Unit +25,000 25,000
2020-09-09 Smith Jason Drew General Counsel Grant or award · Employee Stock Option (right to buy) +60,000 60,000
2020-09-09 Smith Jason Drew General Counsel Grant or award · Restricted Stock Unit +25,000 25,000
2020-09-04 Schoenberg Mark Chief Medical Officer Exercise or conversion +1,041 19,584
2020-09-04 Schoenberg Mark Chief Medical Officer Sale −348 $20.20 $7K 19,236

Page 19 of 25 · 496 trades